Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06445322
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-05-31
Brief Title:
Prescreening Study to Identify Potential Participants for ACDN-01 Clinical Trials
Sponsor:
Ascidian Therapeutics Inc
Organization:
Ascidian Therapeutics Inc
Study Overview
Official Title:
Prescreening Study to Identify Potential Participants with ABCA4-related Retinopathy for ACDN-01 Clinical Trials
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an observational prescreening study Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials
Detailed Description:
The prescreening process will be used to help determine the initial eligibility and interest of potential participants in ACDN-01 clinical trials by conducting assessments of key eligibility criteria before the clinical trial screening procedures are performed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None